CCK-1 receptor modulators

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C548S341500, C548S335100

Reexamination Certificate

active

07456208

ABSTRACT:
Certain imidazole compounds are CCK1 modulators useful in the treatment of CCK1 mediated diseases.

REFERENCES:
patent: 4826868 (1989-05-01), Wachter et al.
patent: 5011851 (1991-04-01), Meanwell
patent: 5051518 (1991-09-01), Murray et al.
patent: 5164381 (1992-11-01), Wachter et al.
patent: 5717100 (1998-02-01), Selnick et al.
patent: 5965583 (1999-10-01), Beers et al.
patent: 6083949 (2000-07-01), Liverton et al.
patent: 0442448 (1991-08-01), None
patent: 0293220 (1994-08-01), None
patent: WO 9205148 (1992-04-01), None
patent: WO 9711704 (1997-04-01), None
patent: WO 9712876 (1997-04-01), None
patent: WO 9901449 (1999-01-01), None
patent: WO 0138324 (2001-05-01), None
patent: WO 0166539 (2001-09-01), None
patent: WO 0185723 (2001-11-01), None
patent: WO 0185724 (2001-11-01), None
patent: WO 0190078 (2001-11-01), None
patent: WO 0407463 (2004-01-01), None
Morton et al. The Journal of Pharmacology and Experimental Therapeutics 2007, 323(2), 562-569.
“Pancreatic Disorder” from http://www.jobaccess.gov.au/JOAC/Advice/DisabilityTwo/Pacreactic—Disorder.htm Jun. 2, 2008.
Berge et al., J. Pharm Sci 1977 vol. 66 pp. 1-19.
Cheng et al., Biochem Pharmacol 1973 vol. 22(23) pp. 3099-3108.
de Tullio, P. et al., Exp. Opin. Invest. Drugs 2000 vol. 9(1) pp. 129-146.
Gigoux, V. et al., J. Biol. Chem. 1999 vol. 274(29) pp. 20457-20464.
Harper, E.A. et al., Br. J. Pharmacol. 1996 vol. 118, pp. 1717-1726.
Hull, R.A. et al., Br. J. Pharmacol. 1993 vol. 108 pp. 734-740.
Klapars, A. et al., J. Am. Chem. Soc. 2001 vol. 123(31) pp. 7727-7729.
Klausner, Y.S. and M. Bodzansky Synthesis 1974 vol. 8 pp. 549-559.
Laufer et al., J Med Chem 2002 vol. 45 pp. 4695-4705.
Meanwell et al., J Med Chem 1992 vol. 35 pp. 3498-3512.
Morton, M.F. et al., Br. J. Pharmacol. 2003 vol. 140(1) pp. 218-224.
Saito, T. et al., J. Am. Chem. Soc. 1998 vol. 120(45) pp. 11633-11644.
Wang, Z. Synth. Commun 1999 vol. 29(13) pp. 2361-2364.
Wolfe, J.P. et al. J. Org. Chem 2000 vol. 65(4) pp. 1158-1174.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

CCK-1 receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with CCK-1 receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CCK-1 receptor modulators will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4039054

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.